Cargando…
Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19?
There are widespread anecdotal reports of seemingly successful treatment among the early (three to seven days from symptoms) stage coronavirus disease 2019 (COVID-19) patients with the drug hydroxychloroquine (HCQ), and randomized placebo-controlled trials of HCQ in outpatient settings are underway....
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585824/ https://www.ncbi.nlm.nih.gov/pubmed/33116907 http://dx.doi.org/10.2147/CLEP.S277889 |